Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4174926
Max Phase: Preclinical
Molecular Formula: C70H83N11O13
Molecular Weight: 1286.50
Molecule Type: Small molecule
Associated Items:
ID: ALA4174926
Max Phase: Preclinical
Molecular Formula: C70H83N11O13
Molecular Weight: 1286.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N[C@@H](Cc1ccc(O)cc1)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)NCC(=O)NCCCCC(=O)N[C@H](CCCCNC(=O)CNC(=O)[C@@H](Cc1cccc2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O
Standard InChI: InChI=1S/C70H83N11O13/c71-54(36-45-25-29-51(82)30-26-45)68(91)80-35-13-23-59(80)67(90)79-57(38-44-14-2-1-3-15-44)65(88)78-58(39-49-20-12-19-47-16-6-7-21-53(47)49)64(87)75-41-62(85)73-33-10-8-22-56(70(93)94)77-61(84)24-9-11-34-74-63(86)42-76-66(89)60-40-48-17-4-5-18-50(48)43-81(60)69(92)55(72)37-46-27-31-52(83)32-28-46/h1-7,12,14-21,25-32,54-60,82-83H,8-11,13,22-24,33-43,71-72H2,(H,73,85)(H,74,86)(H,75,87)(H,76,89)(H,77,84)(H,78,88)(H,79,90)(H,93,94)/t54-,55-,56+,57-,58+,59-,60+/m0/s1
Standard InChI Key: RQGGFOMVIRTVLQ-HJTYUDIQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1286.50 | Molecular Weight (Monoisotopic): 1285.6172 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Olson KM, Keresztes A, Tashiro JK, Daconta LV, Hruby VJ, Streicher JM.. (2018) Synthesis and Evaluation of a Novel Bivalent Selective Antagonist for the Mu-Delta Opioid Receptor Heterodimer that Reduces Morphine Withdrawal in Mice., 61 (14): [PMID:29939746] [10.1021/acs.jmedchem.8b00403] |
Source(1):